SCHEMBL4446778

SCHEMBL4446778

NC1(OC=O)CC=CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL61083 0.77
Hydrochloric Acid SCHEMBL8681308 0.74
SCHEMBL61735 0.72
Hydrochloric Acid SCHEMBL5960763 0.72
SCHEMBL61974 0.72
SCHEMBL60474 0.70 TSHR (0.32)
SCHEMBL61654 0.70 TSHR (0.32)
SCHEMBL62222 0.70 TSHR (0.32)
Hydrochloric Acid SCHEMBL3168559 0.70
Hydrochloric Acid SCHEMBL9009933 0.69 TSHR (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112694650-B Wear-resistant bootleg sole and preparation process thereof 莆田永生鞋业有限公司 2022-12-06 CN claimed
CN-112694650-A Wear-resistant bootleg sole and preparation process thereof 莆田永生鞋业有限公司 2021-04-23 CN claimed
CN-112694650-B Wear-resistant bootleg sole and preparation process thereof 莆田永生鞋业有限公司 2022-12-06 CN disclosed
CN-112694650-A Wear-resistant bootleg sole and preparation process thereof 莆田永生鞋业有限公司 2021-04-23 CN disclosed
US-7632840-B2 Quinazoline compounds for the treatment of hyperproliferative disorders ASTRAZENECA AB (SE) 2009-12-15 US disclosed
EP-1713781-B1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2008-11-05 EP disclosed
US-20070293490-A1 Quinazoline Derivatives ASTRAZENECA AB (SE) 2007-12-20 US disclosed
EP-1713781-A1 QUINAZOLINE DERIVATIVES AstraZeneca AB (SE) 2006-10-25 EP disclosed
WO-2005075439-A1 QUINAZOLINE DERIVATIVES ASTRAZENECA AB (SE) 2005-08-18 WO disclosed